Image pharmaphorum Editor Market Access 12 questions with: Daniel Kohlstaedt Daniel Kohlstaedt, managing director of PurpleLeaf Strategy, with more than 18 years of experience in pharma, talks about his journey through the industry. Market Access Around the world in pharma events Stay up to date with key industry meetings and conferences in 2023 Market Access How to solve a problem like DTx in Europe? The promise of digital therapeutics (DTx) has been widely discussed and debated since the term first began to emerge back in the early 2010s. Market Access CSL opens a new R&D facility in Waltham, Massachusetts On March 27th, global biopharma company CSL opened a new R&D facility in Waltham, Massachusetts. Load more results
Market Access 12 questions with: Daniel Kohlstaedt Daniel Kohlstaedt, managing director of PurpleLeaf Strategy, with more than 18 years of experience in pharma, talks about his journey through the industry.
Market Access Around the world in pharma events Stay up to date with key industry meetings and conferences in 2023
Market Access How to solve a problem like DTx in Europe? The promise of digital therapeutics (DTx) has been widely discussed and debated since the term first began to emerge back in the early 2010s.
Market Access CSL opens a new R&D facility in Waltham, Massachusetts On March 27th, global biopharma company CSL opened a new R&D facility in Waltham, Massachusetts.